[1]
S. Ciotti et al., “Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS) ”, EJCRIM, vol. 8, no. 2, Feb. 2021, doi: 10.12890/2021_002190.